Innovate Corp (VATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,100 | 48,800 | 80,800 | 80,400 | 47,500 |
| Receivables | 241,100 | 194,000 | 278,400 | 254,900 | 247,100 |
| Inventories | 16,000 | 20,800 | 22,400 | 18,900 | 17,000 |
| Other current assets | 82,300 | 127,300 | 136,300 | 182,200 | 131,000 |
| TOTAL | $451,500 | $390,900 | $517,900 | $536,400 | $442,600 |
| Non-Current Assets | |||||
| PPE Net | 141,800 | 133,600 | 154,600 | 165,000 | 169,900 |
| Investments And Advances | 1,800 | 3,600 | 1,800 | 59,500 | 56,000 |
| Intangibles | 292,200 | 299,100 | 306,000 | 317,200 | 335,800 |
| Other Non-Current Assets | 62,800 | 63,900 | 63,300 | 73,600 | 76,300 |
| TOTAL | $498,600 | $500,200 | $525,700 | $615,300 | $638,000 |
| Total Assets | $950,100 | $891,100 | $1,043,600 | $1,151,700 | $1,080,600 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 581,400 | 162,200 | 30,500 | 30,600 | 69,500 |
| Accounts payable and accrued liabilities | 141,400 | 84,800 | 142,900 | 202,500 | 179,200 |
| Accrued Expenses | 122,500 | 109,700 | 70,800 | 65,400 | 93,400 |
| Other current liabilities | 188,800 | 126,300 | 169,600 | 118,700 | 97,400 |
| TOTAL | $1,034,100 | $483,000 | $413,800 | $417,200 | $439,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 80,300 | 500,600 | 679,300 | 683,800 | 556,800 |
| Other Non-Current Liabilities | 51,300 | 51,400 | 85,400 | 120,700 | 121,300 |
| TOTAL | $132,900 | $551,300 | $765,100 | $807,500 | $678,500 |
| Total Liabilities | $1,167,000 | $1,034,300 | $1,178,900 | $1,224,700 | $1,118,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,645 | 13,283 | 7,924 | 7,879 | 7,784 |
| Common Shares | N/A | N/A | N/A | 100 | 100 |
| Retained earnings | -582,500 | -521,900 | -487,300 | -452,100 | -416,200 |
| Other shareholders' equity | 12,200 | 17,500 | 12,300 | 36,300 | 34,300 |
| TOTAL | $-216,900 | $-143,200 | $-135,300 | $-73,000 | $-37,400 |
| Total Liabilities And Equity | $950,100 | $891,100 | $1,043,600 | $1,151,700 | $1,080,600 |